Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jul 13, 2026

Revenue (TTM)
$200.42B
+2.6% YoY
Gross margin
25.9%
EPS (latest q)
$12.58
vs $10.81 est · beat
52-wk position
95.8%
-1.5% vs 52w high · +2.9% 1mo

Price (last ~year)

Elevance Health (ELV) reported Q1 2026 revenue of $50.18 billion and net income of $1.76 billion, representing a 2.6% year-over-year revenue increase against a 16.8% decline in earnings. The company, currently valued at $90.39 billion with a P/E ratio of 17.64, posted quarterly earnings of $12.58 per share, surpassing analyst estimates. Trading at $416.23, the insurer maintains $31.84 billion in total debt with a 3.7x debt-to-EBITDA ratio and an analyst price target of $431.48.

Valuation

Market cap
$90.39B
P/E
17.64
PEG
1.524
P/B
2.059
P/S
0.451
Beta
0.683
Analyst target
$431.48

Quality & returns

Gross margin
25.9%
Operating margin
5.3%
Profit margin
2.6%
ROE
12.1%
ROA
4.0%

Price movement

Last
$416.23
1-month
+2.9%
3-month
+33.4%
RSI (14)
64
vs SMA200
+20.8%
52-wk position
95.8% -1.5% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B
2025-06-30$49.78B$2.63B$1.74B$3.01B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots